The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenvatinib for the treatment of thymic epithelial tumors (TETs): A real-life multicenter experience.
 
Jose Carlos Benitez
No Relationships to Disclose
 
Juan Florez-Arango
No Relationships to Disclose
 
Eric Dansin
No Relationships to Disclose
 
Giuseppe Giaccone
Consulting or Advisory Role - Daiichi; Eisai; Janssen Oncology; Novartis; Radiomics; Sanofi; Sanofi/Regeneron; Spectrum Pharmaceuticals
Research Funding - Cantargia AB (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst)
 
Clemence Basse
No Relationships to Disclose
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; Hengrui Therapeutics; Lilly/ImClone; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Thomas Pierret
Honoraria - Bristol-myers squibb; Pfizer
 
Matteo Giaj Levra
Employment - AstraZeneca Canada
Honoraria - AstraZeneca Canada
Consulting or Advisory Role - AstraZeneca Canada
 
Elvire Pons-Tostivint
No Relationships to Disclose
 
Jennifer Arrondeau
No Relationships to Disclose
 
Mihaela Aldea
No Relationships to Disclose
 
Pascale Missy
No Relationships to Disclose
 
Thierry Molina
No Relationships to Disclose
 
Nicolas Girard
Employment - AstraZeneca (I)
Consulting or Advisory Role - AMGEN; AstraZeneca; Bristol-Myers Squibb; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Benjamin Besse
Research Funding - 4D Pharma (Inst); Abbvie (Inst); Amgen (Inst); Aptitude Health (Inst); AstraZeneca (Inst); BeiGene (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); cergentis (Inst); Chugai Pharma (Inst); Cristal Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genzyme (Inst); GlaxoSmithKline (Inst); Inivata (Inst); Ipsen (Inst); Janssen Oncology (Inst); Lilly (Inst); Onxeo (Inst); OSE Immunotherapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)